Skip to main content

Table 4 Independent predictors of death in the patients receiving echinocandin as antifungal therapy with respect to local guidelines, according to 3 different Cox analysis models

From: Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU

  Hazard ratio 95% CI p
Duration of echinocandin therapy 0.88 0.78–0.99 0.05
RRT on D1 3.05 1.29–7.19 0.01
  Hazard ratio 95% CI p
Empiric therapy (Yes) 1.50 0.57–3.96 0.41
RRT on D1 3.05 1.29–7.19 0.01
  Hazard ratio 95% CI p
Duration of echinocandin therapy 0.91 0.81–1.01 0.07
Empiric therapy (Yes) 1.19 0.43–3.25 0.74
RRT on D1 3.20 1.29–8.00 0.01
  1. D: day; SOFA: sequential organ failure assessment; RRT: renal replacement therapy; CI: confidence interval.